068760.KQ
Celltrion Pharm, Inc. [068760.KQ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
068760.KQ Stock Summary
Top 10 Correlated ETFs
068760.KQ
Top 10 Correlated Stocks
068760.KQ
In the News
068760.KQ Financial details
Company Rating
-
Market Cap
3248.61B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
11 May 2023
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
49.98%
SMA50
36.9%
SMA100
36.6%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
34.05M
Shs Float
17.57M
-
-
-
-
Target Price
-
52W Range
80800.0-99600.0
52W High
-6.93%
52W Low
+14.73%
RSI
71.39
Rel Volume
0.98
Avg Volume
834.56K
Volume
817.42K
Perf Week
17.34%
Perf Month
45.07%
Perf Quarter
46.45%
Perf Half Y
40.45%
-
-
-
-
Beta
0.246069
-
-
Volatility
5060.89%, 14092.66%
Prev Close
-0.96%
Price
92700
Change
-2.83%
Company Profile
- Volume Average 834.56K
- Market Capitalization 3248.61B
- CEO Jung-su Seo
- Headquarters Cheongju,KR
- IPO Date 2004-11-19
-
Website
https://www.celltrionph.com 
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju, South Korea.
